Dummer Wolfgang 4
4 · RIGEL PHARMACEUTICALS INC · Filed Jan 30, 2023
Insider Transaction Report
Form 4
Dummer Wolfgang
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-26+50,000→ 100,000 totalExercise: $2.42Exp: 2032-01-24→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met.
- [F2]The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met.